Research Summary
An anti-tumor drug is a type of medication used to treat cancer by either stopping or slowing down the growth of cancer cells. They work by targeting specific molecules or processes that are essential for the growth and survival of cancer cells. Anti-tumor drugs can be administered through injections, tablets, capsules, or intravenous infusions. They can be used alone or in combination with other treatments like radiation therapy or surgery. Examples of anti-tumor drugs include chemotherapy agents, immunotherapy agents, targeted therapy agents, and hormone therapies. The choice of the drug will depend on the type of cancer and the stage of the disease.
According to DIResearch's in-depth investigation and research, the global Anti-tumor Drug market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Anti-tumor Drug include Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, Astellas, Merck & Co, Sanofi, Bayer, Biogen Idec, Eisai, Teva, Otsuka etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Anti-tumor Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Anti-tumor Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Anti-tumor Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Anti-tumor Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Anti-tumor Drug Include:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Anti-tumor Drug Product Segment Include:
Cytotoxic Drugs
Non-cytotoxic Drugs
Anti-tumor Drug Product Application Include:
Alkylating Agents
Anti-Metabolism Drugs
Platinum Antineoplastic Agents
Anthracycline Antitumor Drugs
Microtubule Stabilizer
Endocrine Therapy Drugs
Immunotherapy Drugs
Gene Therapy Drugs
Targeted Antineoplastic Drugs
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Anti-tumor Drug Industry PESTEL Analysis
Chapter 3: Global Anti-tumor Drug Industry Porter's Five Forces Analysis
Chapter 4: Global Anti-tumor Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Anti-tumor Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Anti-tumor Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Anti-tumor Drug Market Overview 1.1 Product Definition and Statistical Scope 1.2 Anti-tumor Drug Product by Type 1.2.1 Global Anti-tumor Drug Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Cytotoxic Drugs 1.2.3 Non-cytotoxic Drugs 1.3 Anti-tumor Drug Product by Application 1.3.1 Global Anti-tumor Drug Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Alkylating Agents 1.3.3 Anti-Metabolism Drugs 1.3.4 Platinum Antineoplastic Agents 1.3.5 Anthracycline Antitumor Drugs 1.3.6 Microtubule Stabilizer 1.3.7 Endocrine Therapy Drugs 1.3.8 Immunotherapy Drugs 1.3.9 Gene Therapy Drugs 1.3.10 Targeted Antineoplastic Drugs 1.4 Global Anti-tumor Drug Market Revenue Analysis (2019-2030) 1.5 Anti-tumor Drug Market Development Status and Trends 1.5.1 Anti-tumor Drug Industry Development Status Analysis 1.5.2 Anti-tumor Drug Industry Development Trends Analysis 2 Anti-tumor Drug Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Anti-tumor Drug Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Anti-tumor Drug Market Analysis by Regions 4.1 Anti-tumor Drug Overall Market: 2023 VS 2024 VS 2030 4.2 Global Anti-tumor Drug Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Anti-tumor Drug Revenue and Market Share by Region (2019-2024) 4.2.2 Global Anti-tumor Drug Revenue Forecast by Region (2025-2030) 5 Global Anti-tumor Drug Market Size by Type and Application 5.1 Global Anti-tumor Drug Market Size by Type 5.2 Global Anti-tumor Drug Market Size by Application 6 North America 6.1 North America Anti-tumor Drug Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Anti-tumor Drug Market Size by Type 6.4 North America Anti-tumor Drug Market Size by Application 6.5 North America Anti-tumor Drug Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Anti-tumor Drug Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Anti-tumor Drug Market Size by Type 7.4 Europe Anti-tumor Drug Market Size by Application 7.5 Europe Anti-tumor Drug Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Anti-tumor Drug Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Anti-tumor Drug Market Size by Type 8.4 China Anti-tumor Drug Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Anti-tumor Drug Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Anti-tumor Drug Market Size by Type 9.4 APAC (excl. China) Anti-tumor Drug Market Size by Application 9.5 APAC (excl. China) Anti-tumor Drug Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Anti-tumor Drug Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Anti-tumor Drug Market Size by Type 10.4 Latin America Anti-tumor Drug Market Size by Application 10.5 Latin America Anti-tumor Drug Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Anti-tumor Drug Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Anti-tumor Drug Market Size by Type 11.4 Middle East & Africa Anti-tumor Drug Market Size by Application 11.5 Middle East & Africa Anti-tumor Drug Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Anti-tumor Drug Market Revenue by Key Manufacturers (2020-2024) 12.2 Anti-tumor Drug Competitive Landscape Analysis and Market Dynamic 12.2.1 Anti-tumor Drug Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Roche 13.1.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Roche Anti-tumor Drug Product Portfolio 13.1.3 Roche Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Novartis 13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Novartis Anti-tumor Drug Product Portfolio 13.2.3 Novartis Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Celgene 13.3.1 Celgene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Celgene Anti-tumor Drug Product Portfolio 13.3.3 Celgene Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Bristol-Myers Squibb 13.4.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Bristol-Myers Squibb Anti-tumor Drug Product Portfolio 13.4.3 Bristol-Myers Squibb Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Amgen 13.5.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Amgen Anti-tumor Drug Product Portfolio 13.5.3 Amgen Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Johnson & Johnson 13.6.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Johnson & Johnson Anti-tumor Drug Product Portfolio 13.6.3 Johnson & Johnson Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Pfizer 13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Pfizer Anti-tumor Drug Product Portfolio 13.7.3 Pfizer Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Takeda 13.8.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Takeda Anti-tumor Drug Product Portfolio 13.8.3 Takeda Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Eli Lilly 13.9.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Eli Lilly Anti-tumor Drug Product Portfolio 13.9.3 Eli Lilly Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 AstraZeneca 13.10.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 AstraZeneca Anti-tumor Drug Product Portfolio 13.10.3 AstraZeneca Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Astellas 13.11.1 Astellas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Astellas Anti-tumor Drug Product Portfolio 13.11.3 Astellas Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 Merck & Co 13.12.1 Merck & Co Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Merck & Co Anti-tumor Drug Product Portfolio 13.12.3 Merck & Co Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Sanofi 13.13.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Sanofi Anti-tumor Drug Product Portfolio 13.13.3 Sanofi Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 Bayer 13.14.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 Bayer Anti-tumor Drug Product Portfolio 13.14.3 Bayer Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.15 Biogen Idec 13.15.1 Biogen Idec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.15.2 Biogen Idec Anti-tumor Drug Product Portfolio 13.15.3 Biogen Idec Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.16 Eisai 13.16.1 Eisai Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.16.2 Eisai Anti-tumor Drug Product Portfolio 13.16.3 Eisai Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.17 Teva 13.17.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.17.2 Teva Anti-tumor Drug Product Portfolio 13.17.3 Teva Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.18 Otsuka 13.18.1 Otsuka Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.18.2 Otsuka Anti-tumor Drug Product Portfolio 13.18.3 Otsuka Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Anti-tumor Drug Industry Chain Analysis 14.2 Anti-tumor Drug Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Anti-tumor Drug Typical Downstream Customers 14.4 Anti-tumor Drug Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support